As part of a clinical investigation evaluating the efficacy of intrapartum antigen detection for screening for heavy vaginal colonization with group B streptococci (GBS), we compared the performance of modified Bactigen and Directigen GBS latex particle agglutination (LPA) kits. Paired vaginal swabs obtained from women in labor were rapidly transported to the laboratory and used for culturing (both swabs) and LPA testing (one swab by each method). GBS (14, 19) . Intrapartum administration of ampicillin has been demonstrated to be efficacious in preventing early-onset GBS neonatal sepsis and reducing perinatal maternal GBS disease (1, 13-15, 19, 22). We have previously reported our preliminary experiences using modified Bactigen (20) and Directigen (7) latex particle agglutination (LPA) techniques for GBS antigen detection directly from vaginal swabs in order to identify candidates for selective intrapartum chemoprophylaxis in a rapid, timely, and selective fashion. The present study was (20) . The designation of 2+, 3+, or 4+ growth were assigned when at least five colonies of GBS were found on the second-, third-, or fourth-generation streaks, respectively; a 1+ designation was assigned when growth was limited to the primary zone of inoculation. Women with 3+ and 4+ growth were considered heavily colonized, whereas women with 1+ or 2+ growth were considered lightly colonized.
and 99%o. Neither LPA kit was a sensitive indicator of vaginal colonization with GBS or neonatal infection.
Pregnant women with heavy vaginal colonization with group B streptococci (GBS) have an approximately 8 to 10% risk of delivering offspring who have or will sustain earlyonset GBS sepsis (14, 19) . Intrapartum administration of ampicillin has been demonstrated to be efficacious in preventing early-onset GBS neonatal sepsis and reducing perinatal maternal GBS disease (1, 13-15, 19, 22) . We have previously reported our preliminary experiences using modified Bactigen (20) and Directigen (7) latex particle agglutination (LPA) techniques for GBS antigen detection directly from vaginal swabs in order to identify candidates for selective intrapartum chemoprophylaxis in a rapid, timely, and selective fashion. The present study was (20) . The designation of 2+, 3+, or 4+ growth were assigned when at least five colonies of GBS were found on the second-, third-, or fourth-generation streaks, respectively; a 1+ designation was assigned when growth was limited to the primary zone of inoculation. Women with 3+ and 4+ growth were considered heavily colonized, whereas women with 1+ or 2+ growth were considered lightly colonized.
Immediately after inoculation the swabs were used for rapid antigen detection using one Table 3 shows performance specifications for detecting heavy GBS colonization. The sensitivity, specificity, and positive and negative predictive values were similar for the two tests.
In order to directly contrast the performances of Bactigen and Directigen under the most comparable conditions, we examined the LPA test results obtained from paired swabs which were associated with concordant culture results with regard to density of colonization. Identical tests results were recorded for Bactigen and Directigen from 50 of 51 paired swabs which were associated with cultures having the same degree of heavy GBS colonization. Of interest, 12 of the 13 false-positive results were generated by both Bactigen and Directigen.
DISCUSSION
Recognition of the efficacy of intrapartum chemoprophylaxis in the prevention of early-onset neonatal GBS sepsis has prompted the evaluation of several strategies to select appropriate recipients of this treatment. Boyer and Gotoff demonstrated that the combination of GBS-positive vaginal and rectal cultures obtained during the early third trimester and the presence of risk factors at parturition (premature labor, prolonged rupture of membranes, or intrapartum fever) correctly identified candidates for intrapartum chemo- prophylaxis; treatment resulted in a decreased incidence of neonatal GBS colonization and sepsis compared with untreated controls (1). However, concern about the limitations inherent to strategies dependent on antepartum cultures (10) (e.g., absence of prenatal care, presentation with preterm labor, and late acquisition of GBS colonization) and recognition of the occurrence of neonatal sepsis in the absence of conventional risk factors have prompted the evaluation of other methods for selecting candidates for chemoprophylaxis. One alternate approach depends on identifying women who are heavily colonized with GBS at the time of presentation to the labor suite. Utilizing coagglutination techniques on vaginal specimens which required preincubation for 5 h, Lim et al. reported a method which, despite a sensitivity for detecting GBS vaginal colonization among parturients of only 28%, provided the basis for instituting selective chemoprophylaxis which completely prevented neonatal GBS disease (13) . However, the time required for preincubation in this strategy would limit its usefulness in women with labor of short duration. More recent efforts have evaluated the performance of antigen detection methods applied directly to vaginal swabs without preincubation, thus permitting a more timely identification of candidates for intrapartum prophylaxis.
A summary of published performance profiles of several GBS antigen detection tests that have been used directly on vaginal swabs is shown in Table 4 (2, 6, 8, 10-12, 17, 18) . These antigen detection tests utilize nitrous acid extraction and LPA (8) , enzyme extraction and LPA (17) , pronase extraction and LPA (12) , nitrous acid extraction and solidphase immunoassay (17) , and antigen extraction coupled with enzyme immunoassay (6) . Although several of these studies (8, 10, 12, 17) report meager degrees of sensitivity for antigen detection associated with any or heavy GBS growth comparable to our own results, one which assessed Bactigen (11) and several others assessing different products (2, 6, 18) claimed substantially greater sensitivity. Potential limitations of some of these studies include small sample size and prolonged delays between obtaining samples, plating them, and performing antigen detection.
Our study attempted to overcome these limitations. Its sample size represents the largest experience reported to date for the application of any method for rapid detection of GBS. Swabs were processed soon after arrival at the laboratory, typically within 30 min. This timely processing may explain the differences in sensitivities for heavy GBS colonization reported for Bactigen and Directigen in this study (57 and 62%) and in our previous reports (67 and 75%) (7, 20) , which reflected our earlier practice of holding swabs from 1 to 24 h prior to testing. Using swabs which were inoculated in vitro with a standardized concentration of GBS, we have previously demonstrated an apparent increase in the sensitivity of Bactigen and Directigen performed with swabs which were held for 8 to 72 h at either room temperature or 4°C prior to antigen testing as contrasted with the sensitivity of tests performed immediately (unpublished observations). Presumably this enhanced sensitivity reflects postacquisitional propagation of GBS organisms and an increase in concentration of antigen. Perhaps similar delays in the performance of antigen detection testing account, in part, for the superior sensitivity reported by some investigators who evaluated Bactigen and other commercially available products (2, 6, 11, 18) . Previous studies have suggested that heavy maternal vaginal colonization with GBS is the dominant risk factor for early-onset neonatal sepsis (19 (14) nor Towers et al. (18) report the time between obtaining vaginal specimens for GBS antigen detection from lightly colonized parturients and the births of their septic offspring, it is possible that the intervals were sufficient to result in an undetected change in maternal colonization status from light to heavy. Such speculation is consistent with the observation by Morales and Lim that all of the septic infants delivered to purportedly lightly colonized mothers (assessed at admission) were born 12 or more hours following rupture of membranes (14) . Periodic repetition of vaginal sampling and antigen detection testing during the course of prolonged labor might enhance the detection of high-risk (i.e., ultimately heavily colonized) parturients.
Another explanation for the occurrence of GBS sepsis in the offspring of lightly colonized parturients is possible virulence factors peculiar to specific serotypes of GBS. Alternatively, risk of disease may be more strongly associated with host factors rather than with serotype or other factors inherent to the organism. The infected infants in the study by Morales and Lim were all premature (14) . Moresensitive instruments of detection may be necessary for selecting candidates for intrapartum chemoprophylaxis among women with premature labor.
Other methods to detect GBS vaginal colonization rapidly include the use of colorimetric starch serum medium (21) and examination of vaginal or cervical specimens by Gram stain (4, 9, 16) . The former are no more sensitive than rapid antigen detection tests and require a minimum period of incubation of 6 h. Investigators evaluating the use of the Gram stain have reported a wide range of sensitivities (38 to 100%) and a general lack of satisfactory specificity (61 to 69%) (4, 9, 16) .
In summary, the evaluation of these two methods for rapid detection of GBS antigen directly from vaginal swabs showed comparable and somewhat disappointing results. The relative effectiveness of these antigen detection kits or other techniques in identifying parturients for selective intrapartum chemoprophylaxis as a strategy to reduce GBS sepsis in newborns can be determined only in a large clinical trial. A preliminary analysis of data from our trial failed to demonstrate a benefit for a preventive strategy based upon intrapartum use of either Bactigen or Directigen (3). Although treatment of heavily colonized parturients identified through the use of these antigen detection kits may have prevented GBS disease in infants born to heavily colonized women, all seven infants in our study who developed earlyonset GBS bacteremia either were lightly colonized (including three neonates with negative LPA results) or had negative screening cultures (3) . This experience supports the need for more-sensitive methods to identify parturients colonized with GBS. While a test with greater sensitivity will identify an increased number of lightly colonized and presumably low-risk infants, this information can be combined with clinical data (e.g., prolonged labor, gestational age, and maternal fever) as a guide to therapeutic intervention.
